GlassScriptPhysician profile
Julie E Vaughn
NPI 1891808069
$503.38
in general payments reported to CMS, 2019-2025
16 companies · $90.44 in 2025
The $90.44 reported for 2025 was less than what a typical Adolescent Medicine (Pediatrics) provider received nationally (typical 2025 total: $99.31).
See the full distribution for Adolescent Medicine (Pediatrics)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.91 · 2020: $58.83 · 2021: $12.29 · 2022: $52.17 · 2023: $78.23 · 2024: $126 · 2025: $90.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $294.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $65.74 | 2020-2024 | |
| Corium, LLC | $57.62 | 2024-2025 | Azstarys |
| Sanofi Pasteur INC. | $55.20 | 2019-2025 | |
| Tris Pharma INC | $54.18 | 2019-2022 | |
| Sobi, INC | $37.79 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $33.92 | 2019-2024 | Capvaxive, Gardasil 9, Gardasil |
| Verrica Pharmaceuticals INC. | $29.54 | 2023-2025 | Ycanth |
| Takeda Pharmaceuticals U.S.A., INC. | $27.69 | 2019 | |
| Pfizer INC. | $23.57 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $21.64 | 2023 | Flumist Quadrivalent |
| Glaxosmithkline, LLC. | $20.34 | 2023 | Bexsero |
| Aytu Biopharma, INC. | $18.37 | 2020 | |
| Collegium Pharmaceutical, INC. | $16.88 | 2025 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $16.21 | 2024 | Qelbree |
| Arbor Pharmaceuticals, INC. | $12.76 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $11.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Vaughn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.